PT  - JOURNAL ARTICLE
AU  - Sapochnik Daiana
AU  - Raimondi Ana
AU  - Medina Victoria
AU  - Naipauer Julian
AU  - Mesri Enrique
AU  - Coso Omar
TI  - A major Role for Nrf2 transcription factors in cell transformation by KSHV encoded oncogenes
AID  - 10.1101/678342
DP  - 2019 Jan 01
TA  - bioRxiv
PG  - 678342
4099  - http://biorxiv.org/content/early/2019/06/21/678342.short
4100  - http://biorxiv.org/content/early/2019/06/21/678342.full
AB  - Kaposi‘s sarcoma (KS) is the most common tumor in AIDS patients and the highly vascularized patient‘s skin lesions are composed of the cells that derive from the endothelial tissue transformed by the KSHV virus. Heme oxygenase-1 (HO-1) is an enzyme upregulated by the Kaposi‘s sarcoma-associated herpesvirus (KSHV) and highly expressed in human Kaposi Sarcoma (KS) lesions. The oncogenic G protein-coupled receptor (KSHV-GPCR or vGPCR) is expressed by the viral genome in infected cells and is involved in KS development, HO-1 expression and vascular endothelial growth factor (VEGF) expression. We have characterized that vGPCR induces HO-1 expression and HO-1 dependent transformation through the Ga13 subunit of heterotrimeric G proteins and the small GTPase RhoA. We have found here several lines of evidence that support a role for Nrf2 transcription factors and family members in the vGPCR,-Ga13,-RhoA signaling pathway that converges on the HO-1 gene promoter. Our current information assigns a major role to Erk1/2 MAPK pathways as intermediate in signaling from vGPCR to Nrf2, influencing Nrf2 translocation to the cell nucleus, Nrf2 transactivation activity and consequently HO-1 expression. Experiments in nude mice show that the tumorigenic effect of vGPCR is dependent on Nrf2 suggesting this transcription factor or its associated proteins as putative pharmacological or therapeutic targets in KS.